HIGHLIGHTS
- who: David Cibula from the Faculty Charles University have published the research work: Tumour-free distance: a novel prognostic marker in patients with early-stage cervical cancer treated by primary surgery, in the Journal: (JOURNAL) of 30/06/2020
- what: In the whole cohort, 75 patients (20%) were referred to adjuvant treatment for the following reasons: positive parametria , positive vaginal margins , positive LN , other reasons (for details see Supplementary Table S3). The authors compared the prognostic significance of 15 markers, which were assessed by imaging or by pathology according to a standardised protocol. TFD in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.